missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CD300LG/Nepmucin Antibody, Novus Biologicals™
  7. 18655922

CD300LG/Nepmucin Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP2-98158-100ul

 View more versions of this product

Product Code. 18655922

  • £255.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CD300LG/Nepmucin Polyclonal antibody specifically detects CD300LG/Nepmucin in Rat samples. It is validated for ELISA
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CD300LG/Nepmucin
Polyclonal
ELISA 1:5000-1:10000
CD300 antigen like family member G, CD300 antigen-like family member G, CD300 molecule like family member g, CD300 molecule-like family member g, CD300g antigen, CLM-9, CLM9Trem4, CMRF35-like molecule 9, NEPMUCIN, TREM4, TREM-4, Triggering receptor expressed on myeloid cells 4
Produced in rabbits immunized with purified, recombinant Rat CD300LG/Nepmucin (Accession#: XP_002724611.1; Met1-Arg160).
100 μg
Primary
Rat
Purified
ELISA
Unconjugated
0.2 um filtered solution in PBS
Rabbit
Antigen and protein A Affinity-purified
RUO
146894
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.